The antivirulent Staphylococcal sRNA SprC regulates CzrB efflux pump to adapt its response to Zinc toxicity

  1. Helene Le Pabic1
  1. 1 Inserm, BRM - UMR_S 1230, Université de Rennes, 35000 Rennes, France;
  2. 2 Universitéde Rennes, QCPS - IGDR UMR CNRS 6290, F-35042 Rennes, France;
  3. 3 Universitéde Rennes, CNRS UMR 6290 IGDR, BIOSIT,, 35043 Rennes, France;
  4. 4 Inserm, BRM - UMR_S 1230, Université de Rennes, 35000 Rennes, France;
  5. 5 Université de Rennes - Inserm
  1. * Corresponding author; email: yoann.augagneur{at}univ-rennes.fr

Abstract

Bacterial regulatory RNAs (sRNAs) are important players to control gene expression. In S. aureus, SprC is an antivirulent trans-acting sRNA known to base-pair with the major autolysin atl mRNA, preventing its translation. Using MS2-affinity purification coupled with RNA sequencing (MAPS), we looked for its sRNA-RNA interactome and identified fourteen novel mRNA targets. In vitro biochemical investigations revealed that SprC binds two of them, czrB and deoD, and uses a single accessible region to regulate its targets, including Atl translation. Unlike Atl regulation, the characterization of the SprC-czrB interaction pinpointed a destabilization of czrAB co-transcript,leading to a decrease of the mRNA level that impaired CzrB Zinc efflux pump expression. On a physiological stand-point, we showed that SprC expression is detrimental to combat against Zinc toxicity. In addition, phagocyctosis assays revealed a significant, but moderate, increase of czrB mRNA level in a sprC-deleted mutant, indicating a functional link between SprC and czrB upon internalization in macrophages, and suggesting a role in resistance to both oxidative and Zinc burst. Altogether, our data uncover a novel pathway in which SprC is implicated, highlighting the multiple strategies employed by S. aureus to balance virulence using an RNA regulator.

Keywords

  • Received June 7, 2024.
  • Accepted July 24, 2024.

This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml). After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.

ACCEPTED MANUSCRIPT